Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17483529rdf:typepubmed:Citationlld:pubmed
pubmed-article:17483529lifeskim:mentionsumls-concept:C0600097lld:lifeskim
pubmed-article:17483529lifeskim:mentionsumls-concept:C0021102lld:lifeskim
pubmed-article:17483529lifeskim:mentionsumls-concept:C0547040lld:lifeskim
pubmed-article:17483529lifeskim:mentionsumls-concept:C1704229lld:lifeskim
pubmed-article:17483529lifeskim:mentionsumls-concept:C1705604lld:lifeskim
pubmed-article:17483529lifeskim:mentionsumls-concept:C0180307lld:lifeskim
pubmed-article:17483529pubmed:issue7lld:pubmed
pubmed-article:17483529pubmed:dateCreated2007-7-19lld:pubmed
pubmed-article:17483529pubmed:abstractTextAim In a prospective study, we tested the feasibility of implantable cardioverter-defibrillator (ICD) implantation under local anaesthesia (LA) with minimal sedation (MS) vs. short general anaesthesia (SGA) for defibrillation test (DT). METHODS AND RESULTS: We implanted ICDs in 118 patients between October 2002 and November 2003. Surgery was performed under LA with MS. Depending on the day of admission, patients had DT without SGA with a shock delivered when patient is unconscious (MS group, n = 73) or with short general anaesthesia (SGA group, n = 45). The patients were asked to rate the intensity of pain on a 10-point visual analogue scale (VAS) at the end of the implantation procedure and for the patient of MS group just after DT (VAS-DT). Visual analogue scale was not influenced by the type of anaesthesia (MS vs. SGA). Univariate analysis showed that NYHA >III, 3 leads implanted and an incomplete understanding of the explanation on the procedure were risk factors of VAS >4. Only understanding of the explanation on the procedure has an influence on pain in multivariate analysis. CONCLUSION: ICD implantation under MS even for DT is feasible and acceptable for the patient.lld:pubmed
pubmed-article:17483529pubmed:languageenglld:pubmed
pubmed-article:17483529pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17483529pubmed:citationSubsetIMlld:pubmed
pubmed-article:17483529pubmed:statusMEDLINElld:pubmed
pubmed-article:17483529pubmed:monthJullld:pubmed
pubmed-article:17483529pubmed:issn1099-5129lld:pubmed
pubmed-article:17483529pubmed:authorpubmed-author:AnemaJ RJRlld:pubmed
pubmed-article:17483529pubmed:authorpubmed-author:LamblinNicola...lld:pubmed
pubmed-article:17483529pubmed:authorpubmed-author:LacroixDomini...lld:pubmed
pubmed-article:17483529pubmed:authorpubmed-author:KlugDidierDlld:pubmed
pubmed-article:17483529pubmed:authorpubmed-author:MarquiéChrist...lld:pubmed
pubmed-article:17483529pubmed:authorpubmed-author:KacetSalemSlld:pubmed
pubmed-article:17483529pubmed:authorpubmed-author:CordovaHélène...lld:pubmed
pubmed-article:17483529pubmed:authorpubmed-author:BouloMarieMlld:pubmed
pubmed-article:17483529pubmed:authorpubmed-author:DucheminAudre...lld:pubmed
pubmed-article:17483529pubmed:authorpubmed-author:MizonFrédériq...lld:pubmed
pubmed-article:17483529pubmed:issnTypePrintlld:pubmed
pubmed-article:17483529pubmed:volume9lld:pubmed
pubmed-article:17483529pubmed:ownerNLMlld:pubmed
pubmed-article:17483529pubmed:authorsCompleteYlld:pubmed
pubmed-article:17483529pubmed:pagination545-50lld:pubmed
pubmed-article:17483529pubmed:meshHeadingpubmed-meshheading:17483529...lld:pubmed
pubmed-article:17483529pubmed:meshHeadingpubmed-meshheading:17483529...lld:pubmed
pubmed-article:17483529pubmed:meshHeadingpubmed-meshheading:17483529...lld:pubmed
pubmed-article:17483529pubmed:meshHeadingpubmed-meshheading:17483529...lld:pubmed
pubmed-article:17483529pubmed:meshHeadingpubmed-meshheading:17483529...lld:pubmed
pubmed-article:17483529pubmed:meshHeadingpubmed-meshheading:17483529...lld:pubmed
pubmed-article:17483529pubmed:meshHeadingpubmed-meshheading:17483529...lld:pubmed
pubmed-article:17483529pubmed:meshHeadingpubmed-meshheading:17483529...lld:pubmed
pubmed-article:17483529pubmed:meshHeadingpubmed-meshheading:17483529...lld:pubmed
pubmed-article:17483529pubmed:meshHeadingpubmed-meshheading:17483529...lld:pubmed
pubmed-article:17483529pubmed:meshHeadingpubmed-meshheading:17483529...lld:pubmed
pubmed-article:17483529pubmed:meshHeadingpubmed-meshheading:17483529...lld:pubmed
pubmed-article:17483529pubmed:meshHeadingpubmed-meshheading:17483529...lld:pubmed
pubmed-article:17483529pubmed:meshHeadingpubmed-meshheading:17483529...lld:pubmed
pubmed-article:17483529pubmed:meshHeadingpubmed-meshheading:17483529...lld:pubmed
pubmed-article:17483529pubmed:year2007lld:pubmed
pubmed-article:17483529pubmed:articleTitleCan we implant cardioverter defibrillator under minimal sedation?lld:pubmed
pubmed-article:17483529pubmed:affiliationDepartment of Cardiology A, Hôpital Cardiologique de Lille, CHRU, Blvd du Pr Leclercq, F-59037 Lille (Cedex), France. c-marquie@chru-lille.frlld:pubmed
pubmed-article:17483529pubmed:publicationTypeJournal Articlelld:pubmed